Research graph
References from Author reply. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1111/imj.70595
10.1111/imj.70595 · External reference
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease
10.1111/imj.70460 · 2026 · External reference
Idiopathic multicentric castleman disease (iMCD)‐idiopathic plasmacytic lymphadenopathy: a distinct subtype of iMCD‐not otherwise specified with different clinical features and better survival
10.1111/bjh.19334 · 2024 · External reference
Unresolved reference
2024 · External reference
10.3390/ijms231810301
10.3390/ijms231810301 · External reference
10.1002/art.43269
10.1002/art.43269 · External reference
Unresolved reference
External reference
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria
2023 · External reference
Asymptomatic multicentric Castleman disease: a potential early stage of idiopathic MCD
10.1182/bloodadvances.2024013728 · 2024 · External reference
10.1002/art.43269
10.1002/art.43269 · ExternalCitation · doi-reference
Idiopathic multicentric castleman disease (iMCD)‐idiopathic plasmacytic lymphadenopathy: a distinct subtype of iMCD‐not otherwise specified with different clinical features and better survival
10.1111/bjh.19334 · ExternalCitation · doi-reference
Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease
10.1111/imj.70460 · ExternalCitation · doi-reference
10.1111/imj.70595
10.1111/imj.70595 · ExternalCitation · doi-reference
Asymptomatic multicentric Castleman disease: a potential early stage of idiopathic MCD
10.1182/bloodadvances.2024013728 · ExternalCitation · doi-reference
10.3390/ijms231810301
10.3390/ijms231810301 · ExternalCitation · doi-reference
